1. Home
  2. SCL vs JANX Comparison

SCL vs JANX Comparison

Compare SCL & JANX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Stepan Company

SCL

Stepan Company

HOLD

Current Price

$57.92

Market Cap

1.2B

ML Signal

HOLD

Logo Janux Therapeutics Inc.

JANX

Janux Therapeutics Inc.

N/A

Current Price

$14.95

Market Cap

984.3M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
SCL
JANX
Founded
1932
2017
Country
United States
United States
Employees
N/A
N/A
Industry
Package Goods/Cosmetics
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.2B
984.3M
IPO Year
1994
2021

Fundamental Metrics

Financial Performance
Metric
SCL
JANX
Price
$57.92
$14.95
Analyst Decision
Strong Buy
Buy
Analyst Count
1
13
Target Price
$75.00
$47.00
AVG Volume (30 Days)
105.2K
940.4K
Earning Date
04-28-2026
05-08-2026
Dividend Yield
3.23%
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$1,803,737,000.00
$10,000,000.00
Revenue This Year
$6.60
N/A
Revenue Next Year
$5.27
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$41.82
$12.12
52 Week High
$68.00
$35.34

Technical Indicators

Market Signals
Indicator
SCL
JANX
Relative Strength Index (RSI) 57.53 44.19
Support Level $48.96 $13.13
Resistance Level $59.21 $15.49
Average True Range (ATR) 1.97 0.63
MACD -0.17 -0.17
Stochastic Oscillator 53.31 16.27

Price Performance

Historical Comparison
SCL
JANX

About SCL Stepan Company

Stepan Co manufactures and sells a variety of chemicals and chemical-based products. The company organizes itself into three segments based on product type. The surfactants segment, which generates the majority of revenue, sells cleaning agents used in detergents, shampoos, body wash, fabric softeners, toothpastes, and other personal-care products. The polymers segment sells polyurethane used to manufacture rigid foam for thermal insulation, as well as phthalic anhydride used to make plastic components for the construction, automotive, and boating industries. The specialty products segment sells chemicals used in food and flavoring. The majority of Stepan's revenue comes from the United States, followed by France, Poland, the United Kingdom, Brazil, Mexico, and other countries.

About JANX Janux Therapeutics Inc.

Janux Therapeutics Inc is a clinical-stage biopharmaceutical company developing tumor-activated immunotherapies for cancer. The proprietary technology of the company has enabled the development of distinct bispecific platforms: Tumor Activated T Cell Engagers (TRACTr), Tumor Activated Immunomodulators (TRACIr), and Adaptive Immune Response Modulator (ARM) platforms. The TRACTr platform produces T cell engagers (TCEs) with a tumor antigen-binding domain and a CD3 T cell binding domain, while the TRACIr platform produces bispecifics with a tumor antigen-binding domain and a costimulatory CD28 binding domain.

Share on Social Networks: